Jeena Sikho Lifecare Intrinsic Value
Jeena Sikho Lifecare intrinsic value. Jeena Sikho Lifecare (JSLL) median intrinsic value is ₹373.60 from 10 valuation models (range ₹135–₹1125), vs current price ₹449.90 — -17.0% downside (Trading Above Median Value), margin of safety -20.4%. Compare with JSLL fundamental valuation to assess whether the stock is under or overvalued.
JSLL Valuation Methods Summary — DCF, Graham Number & P/E
Jeena Sikho Lifecare intrinsic value across 10 models vs current price ₹449.90 — upside/downside and value range per method. For current market price and key ratios, visit JSLL share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹319.44 | ₹255.55 - ₹383.33 | -29.0% | EPS: ₹14.52, Sector P/E: 22x |
| Book Value Method | asset | ₹373.60 | ₹336.24 - ₹410.96 | -17.0% | Book Value/Share: ₹186.80, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹700.80 | ₹630.72 - ₹770.88 | +55.8% | Revenue/Share: ₹350.40, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹899.80 | ₹809.82 - ₹989.78 | +100.0% | EBITDA: ₹324.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1124.75 | ₹899.80 - ₹1349.70 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹134.97 | ₹121.47 - ₹148.47 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹224.33 | ₹201.90 - ₹246.76 | -50.1% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹899.80 | ₹809.82 - ₹989.78 | +100.0% | ROE: 38.5%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹247.04 | ₹222.34 - ₹271.74 | -45.1% | EPS: ₹14.52, BVPS: ₹186.80 |
| Dividend Yield Method | dividend | ₹180.00 | ₹162.00 - ₹198.00 | -60.0% | DPS: ₹4.50, Target Yield: 2.5% |
JSLL Intrinsic Value vs Market Price — All Valuation Models
Jeena Sikho Lifecare fair value range ₹135–₹1125 vs current market price ₹449.90 across 10 valuation models. Read JSLL dividend history for the complete payout history and dividend yield track record.
JSLL Intrinsic Value Analysis — Undervalued or Overvalued?
Jeena Sikho Lifecare median intrinsic value ₹373.60, current price ₹449.90 — Trading Above Median Value by 17.0%, margin of safety -20.4%.
What is the intrinsic value of JSLL?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Jeena Sikho Lifecare (JSLL) is ₹373.60 (median value). With the current market price of ₹449.90, this represents a -17.0% variance from our estimated fair value.
The valuation range spans from ₹134.97 to ₹1124.75, indicating ₹134.97 - ₹1124.75.
Is JSLL undervalued or overvalued?
Based on our multi-method analysis, Jeena Sikho Lifecare (JSLL) appears to be trading above median value by approximately 17.0%.
JSLL Financial Health — Key Ratios vs Industry Benchmarks
Jeena Sikho Lifecare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.34 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 38.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 36.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.30x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
JSLL Cash Flow Quality — Operating & Free Cash Flow
Jeena Sikho Lifecare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹254 Cr | ₹153 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹85 Cr | ₹53 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹15 Cr | ₹-2 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹16 Cr | ₹7 Cr | Positive Free Cash Flow | 7/10 |